Work

Construction of 5-Aminosalicylic acid–loaded PLGA particle/Panax notoginseng polysaccharide composite microneedles and their therapeutic effects on osteoarthritis in rats

Year: 2026
Type: article
Abstract: Objective 5-Aminosalicylic acid (5-ASA) has anti-inflammatory activity and therapeutic potential for osteoarthritis (OA), but its local delivery remains to be optimized. In this study, Panax notoginseng polysaccharide (PNP) was used as the matrix of dissolving microneedles, and 5-ASA-loaded poly(lactic-co-glycolic acid) particles (5-ASA-PLGA-Ps) were incorporated into the PNP microneedle tip matrix to construct 5-ASA-PLGA-Ps@PNP-MNs. The physicochemical properties, mechanical and skin-piercing performance, release behavior, therapeutic effects, and preliminary biosafety of 5-ASA-PLGA-Ps@PNP-MNs were evaluated. Methods 5-ASA-PLGA-Ps were prepared using an emulsion–solvent evaporation method and characterized by dynamic light scattering, scanning electron microscopy, Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and X-ray diffraction (XRD). 5-ASA-PLGA-Ps@PNP-MNs were then fabricated using a polydimethylsiloxane mold-casting method. Microneedle morphology, mechanical properties, skin insertion and recovery, and drug/particle release were evaluated. A rat OA model was established by anterior cruciate ligament transection (ACLT). Free 5-ASA, 5-ASA-PLGA-Ps, and 5-ASA-PLGA-Ps@PNP-MNs were administered, and therapeutic efficacy was assessed using serum inflammatory cytokine measurements, micro-CT, and histopathological analysis of the knee joints. Major-organ H&E staining and routine hematological analyses were used for preliminary safety evaluation. Results 5-ASA-PLGA-Ps were successfully prepared. The particle size was mainly distributed within approximately 1–2 μm. The particles were generally near-spherical and displayed no sustained marked drift in particle size or zeta potential during the 30-day observation period. FTIR, DSC, and XRD findings suggested attenuation of the original crystalline and thermal characteristics of 5-ASA after PLGA loading. The fabricated 5-ASA-PLGA-Ps@PNP-MNs exhibited a regular array, intact needle structures, sufficient mechanical strength to support skin insertion, and clear formation of skin microchannels. In vitro , the cumulative release of 5-ASA-PLGA-Ps@PNP-MNs from the composite microneedles reached approximately 75%, compared with approximately 53% for 5-ASA@PNP-MNs. In vivo , all 5-ASA formulations induced varying degrees of improvement, whereas the composite microneedle group exhibited a more pronounced trend toward lower serum pro-inflammatory cytokine levels, improvement in knee bone structural abnormalities, and attenuation of cartilage damage and matrix loss. No obvious severe pathological injury was observed in major organs, and most hematological parameters did not display consistent widespread abnormalities. Conclusion The constructed 5-ASA-PLGA-Ps@PNP-MN system exhibited favorable microneedle formation, mechanical performance, and skin-piercing ability and altered the release behavior of 5-ASA from the PNP microneedle matrix. In an ACLT-induced rat OA model, the composite microneedle group displayed more pronounced anti-inflammatory and joint-structure improvement trends and demonstrated favorable preliminary tolerability under the current dosing conditions and observation period. These findings provide an experimental basis for further investigating local 5-ASA delivery for OA and natural polysaccharide-based particle–microneedle composite delivery systems.
Language: English
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236371152
FWCI:
Cites: 42
Cited by:
Related to: 10